中国免疫学杂志2024，Vol.40Issue(6)：1324-1328,5.DOI:10.3969/j.issn.1000-484X.2024.06.035
免疫细胞疗法在IBD治疗中的研究进展
Progress of immunocellular therapy in treatment of IBD
摘要
Abstract
Inflammatory bowel disease(IBD)is a disease characterized by chronic,recurrent intestinal inflammation,includ-ing Crohn's disease(CD)and ulcerative colitis(UC).Etiology and pathogenesis of IBD are unknown,and the treatment is difficult.In recent years,immunocellular therapy represented by regulatory T(Treg)cell therapy and dendritic cell(DC)therapy has developed rapidly in the field of immune-related disease treatment,and some progress has also been made in the treatment of IBD.This review will introduce application and progression of Treg cell therapy and DC therapy in IBD treatment.关键词
炎症性肠病/免疫细胞疗法/调节性T细胞/树突状细胞Key words
Inflammatory bowel disease/Immunocellular therapy/Regulatory T cell/Dendritic cell分类
医药卫生引用本文复制引用
周建伟,张哲,刘霞,孙亚星,王亮,冯百岁..免疫细胞疗法在IBD治疗中的研究进展[J].中国免疫学杂志,2024,40(6):1324-1328,5.基金项目
河南省重点研发与推广专项(科技攻关)(212102310803) （科技攻关）
2021年度河南省医学科技攻关计划联合共建项目(LHGJ20210409,LHGJ20210424,LHGJ20210416). （LHGJ20210409,LHGJ20210424,LHGJ20210416）
